BBH ETF (VanEck Biotech ETF) is managed by VanEck with $353.8M in net assets. BBH expense ratio is 0.35%, holding 26 positions across sectors including Health Care, Unknown, Information Technology. Inception date: 2011-12-20.

BBH performance shows a YTD return of -1.36%. The 1-year return is 22.99% and the 5-year return is 0.24%. BBH dividend yield stands at 0.53%, paid annually.

BBH top holdings include Gilead Sciences Inc (14.2%), Amgen Inc. (14.0%), Vertex Pharmaceuticals Inc (7.8%), Regeneron Pharmaceuticals, Inc. (7.0%), Argenx NV ADR (5.8%). View all BBH holdings, sector breakdown, or dividend history.

BBH can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBH alternatives are available via the screener, along with tax-loss harvesting opportunities.